<DOC>
	<DOC>NCT02493231</DOC>
	<brief_summary>Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.</brief_summary>
	<brief_title>Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia</brief_title>
	<detailed_description />
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Nefopam</mesh_term>
	<criteria>patient who scheduled laparoscopic cholecystectomy under general anesthesia American Society of Anesthesiologist(ASA) class I or II adult patient (age 20 65) patient who has liver disease patient who has kidney disease patient who has diabetes mellitus(DM) or heart disease patient who takes opioid or betablocker patient who has airway disease patient who has allergy with the drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>